Skip to main content

Table 2 Comparison of controls and TLR4 SNP rs4986790 cases divided by BMI Quartiles

From: Obesity-associated hypertension is ameliorated in patients with TLR4 single nucleotide polymorphism (SNP) rs4986790

 

Controls (n = 2698)

Cases (n = 319)

BMI, quartiles

Q1

Q2

Q3

Q4

Q1

Q2

Q3

Q4

Number, n (%)

665/754 (88,2)

674/756 (89,2)

676/752 (89,9)

683/755 (90,5)

89/754 (11,8)

82/756 (10,8)

76/752 (10,1)

72/755 (9,5)

Age, y

56,7 ± 9,4

57,4 ± 9,2

57,0 ± 8,6

57,0 ± 8,9

55,2 ± 10,1

58,7 ± 8,0

57,3 8,1

57,6 ± 9,2

Sex, female n (%)

239 (36)

128 (19)

135 (20)

191 (28)

33 (37)

14 (17)

23 (30)

18 (25)

BMI, kg/m2

22,6 ± 1,7

25,8 ± 0,7

28,2 ± 0,8

32,7 ± 3,0*

22,6 ± 1,7

25,8 ± 0,6

28,1 ± 0,7

33,0 ± 3,3*

Smoking, n (%)

300 (45)

317 (47)

331 (49)

314 (46)

44 (49)

38 (46)

31 (41)

31 (43)

Diabetes, n (%)

80 (12)

81 (12)

68 (10)

134 (20)*

10 (11)

12 (15)

17 (22)

11 (15)

Cholesterolemia, n (%)

337 (51)

393 (58)

379 (56)

410 (60)*

50 (56)

51 (62)

41 (54)

40 (56)

LDL, mg/dl

122,1 ± 40,0

126,5 ± 40,8

126,5 ± 41,8

122,9 ± 41,5

126,7 ± 39,3

124,7 ± 36,8

116,2 ± 36,5

118,1 ± 30,2

HDL, mg/dl

55,3 ± 33,4

49,7 ± 16,3

47,2 ± 16,0

45,4 ± 13,2*

54,4 ± 16,0

48,1 ± 13,5

44,2 ± 11,7

44,6 ± 10,7*

TG, mg/dl

137,3 ± 139,0

154,4 ± 111,7

171,0 ± 104,5

198,1 ± 195,8*

116,7 ± 62,2

184,0 ± 105,0

158,6 ± 121,9

198,9 ± 156,7*

SBP, mmHg

144,7 ± 26,6

144,4 ± 25,5

145,2 ± 25,4

148,5 ± 26,3*

143,3 ± 28,1

146,6 ± 23,6

144,4 ± 26,0

141,5 ± 24,2#

DBP, mmHg

79,4 ± 3,6

79,7 ± 3,8

79,6 ± 3,6

79,8 ± 3,5

80,0 ± 3,9

79,6 ± 2,6

79,3 ± 5,4

79,1 ± 4,6

PP, mmHg

64,9 ± 25,6

65,2 ± 25,3

65,8 ± 25,8

68,8 ± 26,1*

62,8 ± 27,8

66,8 ± 24,6

65,7 ± 25,6

61,2 ± 22,8#

Hypertension, n (%)

359 (54)

380 (56)

386 (57)

417 (61)*

42 (47)

49 (60)

40 (53)

37 (51)

Antihypertensive drugs, n

1,15 ± 1,08

1,24 ± 1,08

1,31 ± 1,07

1,48 ± 1,10*

1,05 ± 1,01

1,32 ± 1,00

1,32 ± 0.97

1,23 ± 1,04

HR, bpm

75,2 ± 12,5

73,4 ± 12,7

73,6 ± 12,7

73,7 ± 12,6

75,3 ± 12,5

74,2 ± 11,6

75,3 ± 11,6

72,8 ± 12,3

MI, %

441 (66)

504 (75)

493 (73)

477 (70)

53 (60)

57 (70)

55 (72)

53 (74)

  1. Data are presented as mean ± SD; other variables are presented as number (%), Q1-Q4: quartile 1-4, BMI quartile ranges: Q1: BMI < 24,64, Q2: BMI ≥24.65-26,89, Q3: BMI ≥ 26. 26.90-29.50, Q4: BMI ≥ 29,51, BMI body mass index, LDL low-density lipoprotein, HDL high-density lipoprotein, TG triglycerides, SBP systolic blood pressure, DBP diastolic blood pressure, PP pulse pressure, HR heart rate, MI myocardial infarction, *P for trend <0.05, # P < 0.05 controls versus TLR4 SNP rs4986790 cases